Bavarian Nordic A/S BAVA.CO Stock
Bavarian Nordic A/S Price Chart
Bavarian Nordic A/S BAVA.CO Financial and Trading Overview
| Bavarian Nordic A/S stock price | 150.7 DKK |
| Previous Close | 212.1 DKK |
| Open | 212.6 DKK |
| Bid | 211.6 DKK x 0 |
| Ask | 211.9 DKK x 0 |
| Day's Range | 211.7 - 216.4 DKK |
| 52 Week Range | 171 - 411 DKK |
| Volume | 52.93K DKK |
| Avg. Volume | 389.07K DKK |
| Market Cap | 16.72B DKK |
| Beta (5Y Monthly) | 1.410344 |
| PE Ratio (TTM) | 51.65854 |
| EPS (TTM) | 19.2 DKK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 354.38 DKK |
BAVA.CO Valuation Measures
| Enterprise Value | 13.14B DKK |
| Trailing P/E | 51.65854 |
| Forward P/E | 11.986418 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.095654 |
| Price/Book (mrq) | 1.7136754 |
| Enterprise Value/Revenue | 3.219 |
| Enterprise Value/EBITDA | 15.292 |
Trading Information
Bavarian Nordic A/S Stock Price History
| Beta (5Y Monthly) | 1.410344 |
| 52-Week Change | -0.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 411 DKK |
| 52 Week Low | 171 DKK |
| 50-Day Moving Average | 196.34 DKK |
| 200-Day Moving Average | 219.63 DKK |
BAVA.CO Share Statistics
| Avg. Volume (3 month) | 389.07K DKK |
| Avg. Daily Volume (10-Days) | 349.8K DKK |
| Shares Outstanding | 77.77M |
| Float | 73.73M |
| Short Ratio | N/A |
| % Held by Insiders | 0.090% |
| % Held by Institutions | 30.51% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.37% |
| Operating Margin (ttm) | 12.02% |
| Gross Margin | 61.16% |
| EBITDA Margin | 21.05% |
Management Effectiveness
| Return on Assets (ttm) | 2.43% |
| Return on Equity (ttm) | 3.70% |
Income Statement
| Revenue (ttm) | 4.08B DKK |
| Revenue Per Share (ttm) | 57.15 DKK |
| Quarterly Revenue Growth (yoy) | 291.19% |
| Gross Profit (ttm) | 1.7B DKK |
| EBITDA | 859.46M DKK |
| Net Income Avi to Common (ttm) | 300.93M DKK |
| Diluted EPS (ttm) | 4.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.97B DKK |
| Total Cash Per Share (mrq) | 40.28 DKK |
| Total Debt (mrq) | 86.7M DKK |
| Total Debt/Equity (mrq) | 0.95 DKK |
| Current Ratio (mrq) | 2.863 |
| Book Value Per Share (mrq) | 123.594 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18438000 DKK |
| Levered Free Cash Flow (ttm) | -1088122240 DKK |
Profile of Bavarian Nordic A/S
| Country | Denmark |
| State | N/A |
| City | Hellerup |
| Address | Philip Heymans Alle 3 |
| ZIP | 2900 |
| Phone | 45 33 26 83 83 |
| Website | https://www.bavarian-nordic.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1040 |
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. It operates in the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Q&A For Bavarian Nordic A/S Stock
What is a current BAVA.CO stock price?
Bavarian Nordic A/S BAVA.CO stock price today per share is 150.7 DKK.
How to purchase Bavarian Nordic A/S stock?
You can buy BAVA.CO shares on the Copenhagen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bavarian Nordic A/S?
The stock symbol or ticker of Bavarian Nordic A/S is BAVA.CO.
Which industry does the Bavarian Nordic A/S company belong to?
The Bavarian Nordic A/S industry is Biotechnology.
How many shares does Bavarian Nordic A/S have in circulation?
The max supply of Bavarian Nordic A/S shares is 77.94M.
What is Bavarian Nordic A/S Price to Earnings Ratio (PE Ratio)?
Bavarian Nordic A/S PE Ratio is 7.84895800 now.
What was Bavarian Nordic A/S earnings per share over the trailing 12 months (TTM)?
Bavarian Nordic A/S EPS is 19.2 DKK over the trailing 12 months.
Which sector does the Bavarian Nordic A/S company belong to?
The Bavarian Nordic A/S sector is Healthcare.
Bavarian Nordic A/S BAVA.CO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Copenhagen_GI OMXCGI | 3465.57 DKK 508.13 USD |
+0.39
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Cap_GI OMXCCAPGI | 2771.14 DKK 406.31 USD |
-0.58
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Benchmark_GI OMXCBGI | 4260.2 DKK 624.64 USD |
+0.54
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Benchmark Cap_GI OMXCBCAPGI | 2664.2 DKK 390.63 USD |
-0.4
|
— — | — — | — — | — - | — — |
| OMX Copenhagen 20 OMXC20 | 2646.56 DKK 388.04 USD |
+0.59
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_ISK_GI OMXNLCISKGI | 613.85 ISK 4.51 USD |
-0.11
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Nordic Health Care N NOMXNHCNI | 5508.52 EUR 6021.56 USD |
-0.45
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Large_Cap_DKK_GI OMXNLCDKKGI | 424.43 DKK 62.23 USD |
-0.09
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Nordic 120 Net Index NOMXN120NI | 2320.95 EUR 2537.11 USD |
+0.24
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Ex OMXC20 Index OMXCXC20GI | 15026.17 DKK 2203.15 USD |
-0.79
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Nordic 120 NOMXN120 | 1615.32 EUR 1765.76 USD |
+0.22
|
— — | — — | — — | — - | — — |
| OMX_Copenhagen_Large_Cap_PI OMXCLCPI | 561.78 DKK 82.37 USD |
+0.4
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Pharmaceuticals CX201030PI | 10605.7 DKK 1555.02 USD |
+1.02
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Cap_PI OMXCCAPPI | 1455.94 DKK 213.47 USD |
-0.6
|
— — | — — | — — | — - | — — |
| OMX Copenhagen Benchmark_PI OMXCBPI | 2318.24 DKK 339.9 USD |
+0.53
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}